Resultados de la búsqueda

Blanco-Rojo R, Perez-Martinez P, Lopez-Moreno J, Martinez-Botas J, Delgado-Lista J, van-Ommen B, Yubero-Serrano E, Camargo A, Ordovas JM, Perez-Jimenez F, Gomez-Coronado D, Lopez-Miranda J. HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial. Sci Rep (2017) 7:12499
Link to the full text in Repisalud
Binek A, Fernandez-Jimenez R, Jorge I, Camafeita E, Lopez JA, Bagwan N, Galan-Arriola C, Pun A, Aguero J, Fuster V, Ibanez B, Vazquez J. Proteomic footprint of myocardial ischemia/reperfusion injury: Longitudinal study of the at-risk and remote regions in the pig model. Sci Rep (2017) 7:12343
Link to the full text in Repisalud
Sala-Vila A, Fernandez-Jimenez R, Pizarro G, Calvo C, Garcia-Ruiz JM, Fernandez-Friera L, Rodriguez MD, Escalera N, Palazuelos J, Macias A, Perez-Asenjo B, Fernandez-Ortiz A, Ros E, Fuster V, Ibanez B. Nutritional preconditioning by marine omega-3 fatty acids in patients with ST-segment elevation myocardial infarction: A METOCARD-CNIC trial substudy. Int J Cardiol (2017) 228:828-33
Ragupathi L, Stribling J, Yakunina Y, Fuster V, McLaughlin MA, Vedanthan R. Availability, Use, and Barriers to Cardiac Rehabilitation in LMIC. Global Heart (2017) 12:323-34
Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, Pascual de la Torre M, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M, ESCARVAL Study Group Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study. PLoS One (2017) 12:e0186196
Smith CE, Van Rompay MI, Mattei J, Garcia JF, Garcia-Bailo B, Lichtenstein AH, Tucker KL, Ordovas JM. Dietary fat modulation of hepatic lipase variant -514 C/T for lipids: a crossover randomized dietary intervention trial in Caribbean Hispanics. Physiol Genomics (2017) 49:592-600
Cordero A, Rodriguez Padial L, Batalla A, Lopez Barreiro L, Torres Calvo F, Castellano JM, Ruiz E, Bertomeu-Martinez V, iCaps study investigators Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain. Results from the CAPS study. Cardiovasc Ther (2017) 35:e12240
Klingel SL, Roke K, Hidalgo B, Aslibekyan S, Straka RJ, An P, Province MA, Hopkins PN, Arnett DK, Ordovas JM, Lai CQ, Mutch DM. Sex Differences in Blood HDL-c, the Total Cholesterol/HDL-c Ratio, and Palmitoleic Acid are Not Associated with Variants in Common Candidate Genes. Lipids (2017) 52:969-80
Fuster V, Gambus F, Patriciello A, Hamrin M, Grobbee DE. The polypill approach - An innovative strategy to improve cardiovascular health in Europe. BMC Pharmacol Toxicol (2017) 18:10
Link to the full text in Repisalud
Tania NP, Maarsingh H, Bos IST, Mattiotti A, Prakash S, Timens W, Gunst QD, Jimenez-Borreguero LJ, Schmidt M, van den Hoff MJB, Gosens R. Endothelial follistatin-like-1 regulates the postnatal development of the pulmonary vasculature by modulating BMP/Smad signaling. Pulm Circ (2017) 7:219-31

Pages